Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Update

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 100 shares, a decline of 99.5% from the January 15th total of 19,700 shares. Based on an average daily trading volume, of 16,900 shares, the short-interest ratio is currently 0.0 days.

Elekta AB (publ) Stock Up 1.8 %

EKTAY stock opened at $6.10 on Friday. The company has a 50 day moving average of $5.66 and a two-hundred day moving average of $6.09. The company has a market cap of $2.34 billion, a price-to-earnings ratio of 24.40 and a beta of 1.22. Elekta AB has a 12-month low of $5.25 and a 12-month high of $8.24. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAY) last announced its quarterly earnings data on Wednesday, November 27th. The company reported $0.06 earnings per share (EPS) for the quarter. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. On average, equities analysts anticipate that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be issued a $0.1072 dividend. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is currently 48.00%.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research report on Wednesday, January 29th.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.